No Detail Found!

Efficacy of Standard Triple Therapy Versus Levofloxacin Based Alternate Therapy against Helicobacter pylori Infection.

Author(s)
Shahzad Latif Akhter Saeed Trust Teaching Hospital, Lahore, Pakistan
Noreen Akther Akhter Saeed Trust Teaching Hospital, Lahore, Pakistan
Sameen Amjed The University of Lahore, Lahore, Pakistan
Junaid Jafar The University of Lahore, Lahore, Pakistan
Bushra Saleem Akhter Saeed Trust Teaching Hospital, Lahore, Pakistan
Muhammad Usman Akhter Saeed Trust Teaching Hospital, Lahore, Pakistan
Tuaha Amjad Akhter Saeed Trust Teaching Hospital, Lahore, Pakistan
Waqas Maqsood The University of Lahore, Lahore, Pakistan
Humaira Waseem The University of Lahore, Lahore, Pakistan
Naim Ashraf Akhter Saeed Trust Teaching Hospital, Lahore, Pakistan
Abstract
Objective: To assess the effectiveness of clarithromycin based standard triple therapy verses levofloxacin based first line therapy against Helicobacter pylori infection. Methods: This prospective observational study was performed at Akhter Saeed Trust Teaching Hospital, Lahore, from May 2016 to 31st May 2017 and comprised of all patients with positive H. pylori, confirmed by gastroscopic biopsy; fulfill the inclusion criteria of this study. Patients were divided into two groups (Group A and Group B). Group A received clarithromycin 500mg, amoxicillin 1g and omeprazole 20mg twice a day for two weeks. In group B levofloxacin 250mg was replaced by clarithromycin whereas rests of medicines remain the same. Patients were followed up at end of first week, second week and at end of treatment to record any adverse effects and cure rate. Data was analyzed by using SPSS version 24.0 and MINITAB V.16. Results: Out of 300 enrolled patients (150 patients in each group), 123 (87.85%) patients cured in group A whereas 134 (92.4%) patients cured in group B. Both treatment regimens were almost equally effective in our population with no statistically significant difference in outcome. Significantly less adverse effects were observed in patients having levofloxacin as compared to standard triple therapy Conclusion: Effectiveness of both standard triple therapy and alternate triple therapy were found satisfactory to be used for treatment in our region. Levofloxacin based alternate therapy is safer to the patients. It can be used in conditions where adverse effects caused by standard therapy are unbearable.
Publication Details
Page(s) 1295-1299
DOI DOI not available
Published Journal: Journal of Pakistan Medical Association, Volume: 68, Issue: 9, Year: 2018

Request the full text from PASTIC

References
MarshallB,WarrenJR, 1984.Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration,The Lancet 323 1311 -5
Vandenplas Y., 2000.Helicobacter pylori infection,World J Gastroenterol 6 20 -
KustersJG,van VlietAH,KuipersEJ, 2006.Pathogenesis of Helicobacter pylori infection,Clin Microbiol Rev 19 449 -90
GattaL,VakilN,VairaD,ScarpignatoC, 2013.Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy,BMJ 347 f4587 -
KuoCH,HuHM,KuoFC,HsuPI,ChenA,YuFJ, 2009.Efficacy of levofloxacin-based rescue therapy for Helicobacter pylori infection after standard triple therapy: a randomized controlled trial,J Antimicrob Chemother 63 1017 -24
2014.Helicobacter pylori prevalence and histopathological findings in dyspeptic patients,J Ayub Med Coll Abbottabad 26 182 -5
KuoCH,KuoFC,HuHM,LiuCJ,WangSS,ChenYH, 2012.The optimal first-line therapy of Helicobacter pylori infection in year 2012,Gastroenterol Res Pract 168361 -
Gut, 2007., 56 772 -81
GisbertJP,BermejoMF,InfanteJM,GallardoBP,BermejoAB, ., 10 -
RodríguezJM, 2009.Levofloxacin, amoxicillin, and omeprazole as first-line triple therapy for Helicobacter pylori eradication,J Clin Gastroenterol 43 384 -5
CammarotaG,CianciR,CannizzaroO,CuocoL,PirozziG,GasbarriniA, 2000.Efficacy of two one week rabeprazole/levofloxacin based triple therapies for Helicobacter pylori infection,Aliment Pharmacol Ther 14 1339 -43
Di CaroS,ZoccoMA,CremoniniF,CandelliM,NistaEC,BartolozziF, 2002.Levofloxacin based regimens for the eradication of Helicobacter pylori,European journal of gastroenterology & hepatology 14 1309 -12
MarzioL,CoraggioD,CapodicasaS,GrossiL,CappelloG, 2006.Role of the preliminary susceptibility testing for initial and after failed therapy of Helicobacter pylori infection with levofloxacin, amoxicillin, and esomeprazole,Helicobacter 11 237 -42
AntosD,Schneider BrachertW,BästleinE,HänelC,HaferlandC,BuchnerM, .7 Day Triple Therapy of Helicobacter pylori Infection with Levofloxacin, Amoxicillin, and High Dose Esomeprazole in Patients with Known Antimicrobial Sensitivity, -
Helicobacter, 2006., 11 39 -45
RispoA,Di GirolamoE,CozzolinoA,BozziR,MoranteA,PasqualeL, 2007.Levofloxacin in First-line Treatment of Helicobacter pylori Infection,Helicobacter 12 364 -5
NazF,MalikS,AfzalS,AnwarSA, 2013.Frequency of seropositivity of helicobacter pylori in patients presenting with dyspepsia,J Ayub Med Coll Abbottabad 25 50 -4
1997.,Eur J Gastroenterol Hepatol 9 1 -2
MalfertheinerP,BazzoliF,DelchierJC,CelinskiK,GiguereM,RiviereM, 2011.Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial, 377 905 -13
GisbertJP, 2010.Sequential or Concomitant Therapy for Helicobacter pylori Eradication? In Response,J Clin Gastroenterol 44 658 -9
GrahamDY,FischbachL, 2010.Helicobacter pylori treatment in the era of increasing antibiotic resistance,Gut 59 1143 -53
GrahamDY,LuH,YamaokaY., 2007.A report card to grade Helicobacter pylori therapy,Helicobacter 12 275 -8
Caspian J InternMed, 2016., 7 267 -71
GopalR,ElamuruganTP,KateV,JagdishS,BasuD., 2013.Standard triple versus levofloxacin based regimen for eradication of Helicobacter pylori,World J Gastrointest Pharmacol Ther 4 23 -7
2010.Levofloxacin-based triple therapy for first-line Helicobacter pylori eradication treatment: a multi-central, randomized, controlled clinical study,Zhonghua Yi XueZaZhi 90 79 -82
2013.The efficacy of levofloxacin-based triple therapy for first-line helicobacter pylori eradication,Med Arc 67 348 -50
0

Citations

0

Downloads

79

Views